Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David R. Mauerhan is active.

Publication


Featured researches published by David R. Mauerhan.


Journal of Arthroplasty | 1998

Relationship between length of stay and manipulation rate after total knee arthroplasty.

David R. Mauerhan; Jeffrey G. Mokris; An Ly; Gary M. Kiebzak

We hypothesized that a pattern of decreasing postoperative length of stay (LOS) in the hospital could lead to an increased rate of manipulation after total knee arthroplasty (TKA). The decision to manipulate is based on the patients ability to perform normal physical activities, which may in large part be dependent on adequate knee flexion (ie, range of motion [ROM]). Decreased exposure to physical therapy (as a result of decreased LOS) may be a contributing factor leading to impaired functional ROM in the 6-week postoperative period. We examined records from 745 patients (2 surgeons) who had a primary TKA from 1993 to 1996. At our institution, development and implementation of clinical pathways resulted in a significant decrease in the average LOS beginning in 1993. The average LOS in 1993 was 6.4 +/- 1.8 days (mean +/- SD) and progressively decreased to 4.4 +/- 1.0 days in 1996 (P < .0001). The rate of manipulation (patients manipulated at 6 weeks/total number of patients receiving TKA) was 6.0% in 1993 and increased to 11.3% (P = .09) in 1994, 13.5% (P = .02) in 1995, and 12.0% (P = .05) in 1996. In the period 1993-1996, patients requiring manipulation consistently had a lower ROM at discharge from the hospital (69.0 +/- 10 degrees, n = 67, P < .0001) compared with patients not requiring manipulation (80.7 +/- 10.6 degrees, n = 542). The relatively low frequency and charge for manipulation may justify the decision to decrease patient exposure to physical therapy through reduction in LOS. As efforts to decrease LOS continue, however, we must aggressively manage patients and provide adequate exposure to inpatient and outpatient physical therapy to ensure optimal ROM results.


Journal of Arthroplasty | 1997

Intra-articular morphine and/or bupivacaine in the management of pain after total knee arthroplasty

David R. Mauerhan; Michael L. Campbell; Joshua S. Miller; Jeffrey G. Mokris; Alexia M. Gregory; Gary M. Kiebzak

The purpose of this study was to determine if intra-articular injection of morphine or bupivacaine significantly decreased postoperative pain as well as the use of intravenous narcotics for pain relief in patients undergoing total knee arthroplasty (TKA). In a prospective, double-blind, randomized fashion, 105 patients undergoing TKA were divided into the following 4 groups defined by the intra-articular injection they received: group 1 (n = 27) received saline solution, group 2 (n = 26) received morphine sulfate (5 mg), group 3 (n = 24) received bupivacaine (50 mg), and group 4 (n = 28) received a combination of morphine sulfate and bupivacaine. The injections were administered immediately after wound closure by the Hemovac drainage tubing that remained clamped for 45 minutes after surgery to allow for absorption. Before surgery and at 2, 4, 6, 24, and 48 hours after surgery, pain intensity was recorded using a visual analog scale. Postoperative supplemental intravenous morphine and/or meperidine was administered via a patient-controlled analgesia device, and 24-hour drug usage was tabulated. Results were suggestive of a modest short-term reduction in pain scores in the morphine and bupivacaine treatment groups compared with placebo (saline); however, results were statistically significant only at 4 hours because of the great variability in the pain score data. The total amount of postoperative pain medication used in the first 24 hours after surgery was not statistically significant between the 4 treatment groups. Thus, the results put into question the benefit of postoperative intra-articular administration of morphine or bupivacaine in patients undergoing TKA.


Arthritis Research & Therapy | 2010

Calcium deposition in osteoarthritic meniscus and meniscal cell culture

Yubo Sun; David R. Mauerhan; Patrick R Honeycutt; Jeffrey S. Kneisl; H. James Norton; Natalia Zinchenko; Edward N. Hanley; Helen E. Gruber

IntroductionCalcium crystals exist in the knee joint fluid of up to 65% of osteoarthritis (OA) patients and the presence of these calcium crystals correlates with the radiographic evidence of hyaline cartilaginous degeneration. This study sought to examine calcium deposition in OA meniscus and to investigate OA meniscal cell-mediated calcium deposition. The hypothesis was that OA meniscal cells may play a role in pathological meniscal calcification.MethodsStudies were approved by our human subjects Institutional Review Board. Menisci were collected during joint replacement surgeries for OA patients and during limb amputation surgeries for osteosarcoma patients. Calcium deposits in menisci were examined by alizarin red staining. Expression of genes involved in biomineralization in OA meniscal cells was examined by microarray and real-time RT-PCR. Cell-mediated calcium deposition in monolayer culture of meniscal cells was examined using an ATP-induced 45calcium deposition assay.ResultsCalcium depositions were detected in OA menisci but not in normal menisci. The expression of several genes involved in biomineralization including ENPP1 and ANKH was upregulated in OA meniscal cells. Consistently, ATP-induced calcium deposition in the monolayer culture of OA meniscal cells was much higher than that in the monolayer culture of control meniscal cells.ConclusionsCalcium deposition is common in OA menisci. OA meniscal cells calcify more readily than normal meniscal cells. Pathological meniscal calcification, which may alter the biomechanical properties of the knee meniscus, is potentially an important contributory factor to OA.


BMC Musculoskeletal Disorders | 2010

Analysis of meniscal degeneration and meniscal gene expression

Yubo Sun; David R. Mauerhan; Patrick R Honeycutt; Jeffrey S. Kneisl; James Norton; Edward N. Hanley; Helen E. Gruber

BackgroundMenisci play a vital role in load transmission, shock absorption and joint stability. There is increasing evidence suggesting that OA menisci may not merely be bystanders in the disease process of OA. This study sought: 1) to determine the prevalence of meniscal degeneration in OA patients, and 2) to examine gene expression in OA meniscal cells compared to normal meniscal cells.MethodsStudies were approved by our human subjects Institutional Review Board. Menisci and articular cartilage were collected during joint replacement surgery for OA patients and lower limb amputation surgery for osteosarcoma patients (normal control specimens), and graded. Meniscal cells were prepared from these meniscal tissues and expanded in monolayer culture. Differential gene expression in OA meniscal cells and normal meniscal cells was examined using Affymetrix microarray and real time RT-PCR.ResultsThe grades of meniscal degeneration correlated with the grades of articular cartilage degeneration (r = 0.672; P < 0.0001). Many of the genes classified in the biological processes of immune response, inflammatory response, biomineral formation and cell proliferation, including major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1), integrin, beta 2 (ITGB2), ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), ankylosis, progressive homolog (ANKH) and fibroblast growth factor 7 (FGF7), were expressed at significantly higher levels in OA meniscal cells compared to normal meniscal cells. Importantly, many of the genes that have been shown to be differentially expressed in other OA cell types/tissues, including ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) and prostaglandin E synthase (PTGES), were found to be expressed at significantly higher levels in OA meniscal cells. This consistency suggests that many of the genes detected in our study are disease-specific.ConclusionOur findings suggest that OA is a whole joint disease. Meniscal cells may play an active role in the development of OA. Investigation of the gene expression profiles of OA meniscal cells may reveal new therapeutic targets for OA therapy and also may uncover novel disease markers for early diagnosis of OA.


Journal of Arthroplasty | 1997

Collection of surgical specimens in total joint arthroplasty. Is routine pathology cost effective

Michael L. Campbell; Alexia M. Gregory; David R. Mauerhan

A retrospective review of 715 consecutive cases of total joint arthroplasty (283 hips, 432 knees), performed for a variety of indications during 1992 and 1993, was undertaken to assess the cost effectiveness of routine pathologic examination. The charts were reviewed for preoperative, operative, and pathologic diagnosis, and any discrepancies in diagnosis were noted. Particular attention was paid to pathologic findings suggestive of neoplasia or rheumatoid arthritis that were not noted in the preoperative or operative diagnoses. Six of the 715 cases fit into this category, but all failed to have any clinical significance. No alteration in patient care resulted from routine pathologic examination. This paper questions the necessity of routinely submitting pathologic specimens in uncomplicated total hip and knee arthroplasty.


Journal of Arthroplasty | 2003

Relationship between length of stay and dislocation rate after total hip arthroplasty

David R. Mauerhan; Robert P Lonergan; Jeffrey G. Mokris; Gary M. Kiebzak

The purpose of this study was to determine if decreased postoperative inpatient time (length of stay; LOS) after total hip arthroplasty (THA) was correlated with an increase in the dislocation rate after discharge. Reduced access to physical therapy, nursing reinforcement of dislocation precautions, and medical supervision could lead to a higher rate of adverse behaviors (such as inappropriate flexion and rotation) and accidents that might have otherwise been avoided in the initial 3 -months after surgery. We examined records from 850 patients (2 surgeons) who underwent primary THA from 1993 to 1998. LOS had progressively decreased over the 4 years since implementation of a clinical pathway (CP) in late 1993. The average LOS in 1992 was 6.6 days and was lowest in 1998 at 3.9 days. The dislocation rate before the CP was 0.5%. The dislocation rate increased significantly to 3.9% after implementation of the CP (P =.015). Use of the CP offers numerous advantages but is associated with a higher dislocation rate.


The Open Rheumatology Journal | 2012

Histological Examination of Collagen and Proteoglycan Changes in Osteoarthritic Menisci

Yubo Sun; David R. Mauerhan; Jeffrey S. Kneisl; H. James Norton; Natalia Zinchenko; Jane A. Ingram; Edward N. Hanley; Helen E. Gruber

This study sought to examine collagen and proteoglycan changes in the menisci of patients with osteoarthritis (OA). Collagens were examined using picrosirius red, and hematoxylin and eosin. Proteoglycans were examined using safranin-O and alcian blue. Types I and II collagens and aggrecan were examined using immunochemistry. Severe loss of collagens was observed to occur in OA menisci, particularly in the middle and deep zones and collagen networks were less organized than those of normal menisci. In contrast, proteoglycan staining in the middle and deep zones of OA meniscus increased compared to normal control menisci. Immunohistochemistry indicated that types I and II collagens were co-localized and the loss of types I collagen in OA menisci appeared more severe in the middle and deep zones than that in the surface zones. The loss of type II collagen however was severe across all three zones. Immunohistochemistry also indicated elevated aggrecan staining in OA menisci. These findings together indicate that severe loss of collagens and intrameniscal degeneration are hallmarks of OA menisci and that extracellular matrix degeneration occurred in OA menisci follows a pathway different from that occurred in OA articular cartilage. These findings are not only important for a better understanding of the disease process but also important for the development of novel structure-modifying drugs for OA therapy.


Journal of Arthroplasty | 2008

Tibial Post Failures in a Condylar Posterior Cruciate Substituting Total Knee Arthroplasty

B. Sonny Bal; David Greenberg; Stephen Li; David R. Mauerhan; Loren G. Schultz; Kenneth Cherry

In posterior-stabilized total knee arthroplasties, a femoral cam and polyethylene tibial post are commonly used to restore posterior stability after sacrifice of the posterior cruciate ligament. This article reports a high incidence of early tibial post failures in one design of prosthesis and examines the variables that may have contributed to such. Five hundred sixty-four consecutive posterior-stabilized total knees were implanted in 512 patients, using a total knee prosthesis with a polyethylene tibial post and femoral cam. Clinical and radiographic outcomes were measured at a mean follow-up of 40 months after surgery (range, 24-83 months). At follow-up, 70 knees in 62 patients (12%) had undergone revision surgery because of symptoms related to catastrophic failure of the tibial post.


Journal of Arthroplasty | 1993

Effect of Postoperative Reinfusion Systems on Hemoglobin Levels in Primary Total Hip and Total Knee Arthroplasties A Prospective Randomized Study

David R. Mauerhan; Donna Nussman; Jeffrey G. Mokris; Walter B. Beaver

A prospective randomized study was undertaken to quantify the effect of reinfusion of postoperative shed blood drainage on the hemoglobin levels in patients undergoing elective primary total hip arthroplasty (THA) and total knee arthroplasty (TKA). One hundred eleven patients were enrolled between December 1990 and August 1991. There were 42 THAs and 69 TKAs. The study group consisted of 57 patients (35 TKAs and 22 THAs) who received a CBC ConstaVac (Stryker Surgical, Kalamazoo, MI) reinfusion system. The control group consisted of 54 patients (34 TKAs and 20 THAs) who received a ConstaVac collection unit. Postoperative drainage volumes were recorded for both groups. In addition, the volume of reinfused blood was recorded for the study group. Postoperative hemoglobins were recorded on postoperative days 1, 3, and 6, the latter reflecting the discharge hemoglobin level. All patients were encouraged to predeposit two units of autologous blood for both THAs and TKAs. This study showed no statistically significant difference in the postoperative hemoglobin levels between the study and control groups at anytime. Additionally, there was no statistically significant difference between hemoglobin levels and drainage volumes in both the THA and TKA study groups, compared to their respective control groups. The results of this study suggest that reinfusion units are not necessary in THAs and TKAs as a matter of routine use.


Journal of Arthroplasty | 1997

Integral porous femoral stem: 5- to 8-year follow-up study

David R. Mauerhan; Joseph Mesa; Alexia M. Gregory; Jeffrey G. Mokris

The outcome of total hip arthroplasty without cement was prospectively followed in patients who received a titanium taper wedge femoral component with a circumferential titanium plasma spray coating on the proximal surface (Integral femoral stem, Biomet, Warsaw, IN). One hundred ninety femoral components were implanted in 179 patients. Nine patients (9 hips) died prior to their 5-year examination, leaving 170 patients available for follow-up evaluation. Thirty-one of the 170 patients (33 hips) were lost at an intermediate follow-up period of 5 years. (mean, 5.8 years, range; 5-8 years), giving a follow-up rate of 82% for patients and hips. The preoperative diagnoses included osteoarthritis (91 hips), avascular necrosis (38), post-traumatic arthritis (10), rheumatoid arthritis (4), congenital dislocation of the hip (3), and fractures (2). The 78 men and 61 women had a mean age of 55 years (range, 18-81 years) and a mean weight of 81 kg (range, 50-136 kg). Pre-operative Harris pain and function scores for the hip were 19.9 (range, 0-40) and 55.6 (range, 12-84), respectively. At the most recent follow-up visit, the mean pain score increased to 41.2 (range, 10-44) and the mean function score increased to 93.5 (range, 6-100). Thigh pain was present in 4% of the hips at the most recent follow-up visit. Radiographically, 99% of the femoral components demonstrated spot welds in the porous-coated zone. Two hips had demarcation of the femoral component in the porous-coated zone consistent with fibrous fixation. None of the femoral stems had been revised and there were no signs of aseptic loosening. Additionally, there were no cases of pain that could be directly attributed to the stem and there was no evidence of distal femoral osteolysis. It is concluded that the integral femoral stem provides excellent clinical and radiographic results at intermediate follow-up periods.

Collaboration


Dive into the David R. Mauerhan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yubo Sun

Carolinas Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrea Roberts

Carolinas Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jane A. Ingram

Carolinas Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Cox

Carolinas Medical Center

View shared research outputs
Top Co-Authors

Avatar

Alex J. Kiraly

Carolinas Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge